Literature DB >> 26577121

Approach to the Porta Hepatis During Cytoreductive Surgery: Technical Considerations.

N Aydin1, A Sardi2, V Milovanov3.   

Abstract

Peritoneal carcinomatosis has until recently been considered uniformly fatal; it results in intestinal obstructions, eventually leading progression of disease and death. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy have become important options for patients with peritoneal carcinomatosis. Completeness of cytoreduction is a major determinant of survival. Frequently, the porta hepatis and the lesser sac are massively involved by tumor. Encasement of portal triad, lesser omentum, retrohepatic vena cava, duodenum, and stomach is frequently seen. The proximity to major portal structures as well as the retrohepatic vena cava makes this dissection challenging. This is the area where meticulous surgical technique and expertise are necessary to obtain complete removal of tumor. Some specific technical considerations are important to assure that all tumor is safely removed.

Entities:  

Mesh:

Year:  2016        PMID: 26577121     DOI: 10.1245/s10434-015-4872-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

Review 1.  Cholecystectomy, porta hepatis stripping, and omental bursectomy.

Authors:  Joo-Hyuk Son; Suk-Joon Chang
Journal:  Gland Surg       Date:  2021-03

2.  Hepatic bridge and round ligament of the liver during cytoreductive surgery: a retrospective cohort.

Authors:  Selcuk Gulmez; Erdal Polat; Ugur Duman; Aziz Serkan Senger; Orhan Uzun; Omer Ozduman; Ayhan Oz; Ismail Ege Subasi; Mustafa Duman
Journal:  Langenbecks Arch Surg       Date:  2021-11-29       Impact factor: 3.445

3.  A case report of symptomatic gallbladder disease in the setting of peritoneal carcinomatosis originating from invasive lobular carcinoma of the breast.

Authors:  David Brinkman; Subhasis Misra; Nail Aydin
Journal:  Int J Surg Case Rep       Date:  2016-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.